Japanese group faces claim over alopecia therapy

UPDATED: A Canadian life sciences company has launched an ICDR arbitration against a Japanese cosmetics group over licensing of a cell therapy for pattern hair loss.

Unlock unlimited access to all Global Arbitration Review content